Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized 129Xe MRI vs 133Xe Scintigraphy for Lung Transplant Evaluation
NCT03418090Phase 3Completed
- Sponsor
- Polarean Imaging
- Start
- Aug 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hyperpolarized xenon gas in Lung disease, sponsored by Polarean Imaging. Started Aug 2018; status: completed.
02
Drugs
hyperpolarized xenon gas
03
Conditions
Lung disease
Beyond the preview
Go deeper on NCT03418090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03418090.